Zobrazeno 1 - 10
of 1 049
pro vyhledávání: '"Burcu M"'
Autor:
Esentepe, Burcu M.1 (AUTHOR) burcuesentepe@gmail.com, Günçe, Kağan1 (AUTHOR)
Publikováno v:
Housing Studies. Nov2024, Vol. 39 Issue 11, p2852-2873. 22p.
Autor:
Wang E; Epidemiology, Merck & Co., Inc., Rahway, New Jersey, USA.; Biostatistics and Research Decision Sciences (BARDS), Merck & Co., Inc., Rahway, New Jersey, USA., Mott K; Epidemiology, Merck & Co., Inc., Rahway, New Jersey, USA.; Biostatistics and Research Decision Sciences (BARDS), Merck & Co., Inc., Rahway, New Jersey, USA., Zhang H; Biostatistics and Research Decision Sciences (BARDS), Merck & Co., Inc., Rahway, New Jersey, USA., Gazit S; Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel., Chodick G; Tel Aviv University, Tel Aviv, Israel., Burcu M; Epidemiology, Merck & Co., Inc., Rahway, New Jersey, USA.; Biostatistics and Research Decision Sciences (BARDS), Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Oct; Vol. 33 (10), pp. e70019.
Autor:
Liu X; Epidemiology, Biostatistics and Research Decision Sciences, Merck & Co., Inc., West Point, Pennsylvania, USA., Alipour GH; Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Shao C; Epidemiology, Biostatistics and Research Decision Sciences, Merck & Co., Inc., West Point, Pennsylvania, USA., Burcu M; Epidemiology, Biostatistics and Research Decision Sciences, Merck & Co., Inc., West Point, Pennsylvania, USA., Bortnichak E; Epidemiology, Biostatistics and Research Decision Sciences, Merck & Co., Inc., West Point, Pennsylvania, USA., Vo T; Epidemiology, Biostatistics and Research Decision Sciences, Merck & Co., Inc., West Point, Pennsylvania, USA., Yu CL; Epidemiology, Biostatistics and Research Decision Sciences, Merck & Co., Inc., West Point, Pennsylvania, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5851.
Autor:
Alipour-Haris G; University of Florida, Gainesville, Florida, USA.; Merck & Co., Inc., Rahway, New Jersey, USA., Liu X; Merck & Co., Inc., Rahway, New Jersey, USA., Acha V; Merck & Co., Inc., Rahway, New Jersey, USA., Winterstein AG; University of Florida, Gainesville, Florida, USA., Burcu M; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e13903.
Autor:
Gini R; ARS Toscana, Florence, Italy., Pajouheshnia R; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain., Gardarsdottir H; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Data Science & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands.; University of Iceland, Reykjavik, Iceland., Bennett D; Takeda Development Center Americas, Cambridge, Massachusetts, USA., Li L; Epidemiology and Benefit Risk, Sanofi, Bridgewater, New Jersey, USA., Gulea C; Center for Observational and Real-World Evidence, MSD, Zürich, Switzerland., Wientzek-Fleischmann A; Daiichi-Sankyo Europe, Germany., Bazelier MT; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands., Burcu M; Department of Epidemiology, Merck & Co., Inc., Rahway, New Jersey, USA., Dodd C; Panalgo, USA., Durán CE; Department of Data Science & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands., Kaplan S; Teva Pharmaceutical Industries Ltd., Israel., Lanes S; Carelon Research, Wilmington, Delaware, USA., Marinier K; IQVIA, Courbevoie, France., Roberto G; ARS Toscana, Florence, Italy., Soman K; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands., Zhou X; Global Medical Epidemiology, Pfizer Inc. New York, USA., Platt R; McGill University, Montreal, Canada., Setoguchi S; Rutgers University, New Jersey, USA., Hall GC; Gillian Hall Epidemiology, UK.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 May; Vol. 33 (5), pp. e5787.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wharton GT; Office of Pediatric Therapeutics, US Food and Drug Administration, Silver Spring, Maryland, USA., Becker C; Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy & Epidemiology, Department of Pharmaceutical Sciences, University Basel, Basel, Switzerland., Bennett D; Global Evidence and Outcomes, Safety Pharmacoepidemiology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Burcu M; Department of Epidemiology, Merck & Co., Inc., Rahway, New Jersey, USA., Bushnell G; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, NJ, USA; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey, USA., Ferrajolo C; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Naples, Italy.; Department of Experimental Medicine, Section of Pharmacology, 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Naples, Italy., Kaplan S; Department Pharmacoepidemiology, Teva Pharmaceutical Industries Ltd, Netanya, Israel., McMahon AW; Office of Pediatric Therapeutics, US Food and Drug Administration, Silver Spring, Maryland, USA., Movva N; EpidStrategies, A Division of ToxStrategies Inc, Rockville, Maryland, USA., Raman SR; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA., Scholle O; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany., Suh M; EpidStrategies, A Division of ToxStrategies Inc, Rockville, Maryland, USA., Sun JW; Safety Surveillance Research, Pfizer Inc., New York, New York, USA., Horton DB; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, NJ, USA; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey, USA.; Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Jan; Vol. 33 (1), pp. e5695. Date of Electronic Publication: 2023 Sep 10.
Autor:
Shui IM; Merck & Co., Inc., Rahway, NJ, USA., Burcu M; Merck & Co., Inc., Rahway, NJ, USA., Shao C; Merck & Co., Inc., Rahway, NJ, USA., Chen C; Merck & Co., Inc., Rahway, NJ, USA., Liao CY; University of Wisconsin-Madison, Health Services Research in Pharmacy, Madison, WI, USA., Jiang S; Merck & Co., Inc., Rahway, NJ, USA., Cristescu R; Merck & Co., Inc., Rahway, NJ, USA., Parikh RB; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. ravi.parikh@pennmedicine.upenn.edu.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. ravi.parikh@pennmedicine.upenn.edu.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Dec 06. Date of Electronic Publication: 2023 Dec 06.
Publikováno v:
Journal of back and musculoskeletal rehabilitation.
BACKGROUND: Adhesive capsulitis (AC) is a common musculoskeletal disease characterized with shoulder pain, limitation of range of motion (ROM) and disability. Although physical therapy is used in the treatment of AC, studies on its effectiveness are